Interim results from investigator-assessed responses in first 40 patients from TSC1 and TSC2 arms demonstrate sustained tumor reductions in heavily pre-treated population80 patients now enrolled in PRECISION1 supporting

AADI

Lithium Argentina Has Growth Potential, But Analyst Cautions About Valuation Concerns

By Nabaparna Bhattacharya

October 4, 4:20 PM

BMO Capital Markets analyst Joel Jackson resumed coverage on Lithium Americas (Argentina) Corp. (NYSE: LAAC)

News

Quotient Announces U.S. Launch Of Shopmium Cash-Back App To Enable Brands To Engage And Influence Consumers

By Benzinga Newsdesk

October 26, 9:19 AM

Direct-to-consumer app combines seamless consumer experience with proprietary technology to increase brand trial and loyalty and facilitate measurable online and offline shopper interactions. Quotient (NYSE:QUOT), the

QUOT

Intel CEO Sees First Half Server Consumptions To Come Down Year-On-Year

Related Posts

Evercore ISI Group Maintains Outperform on Applied Materials, Raises Price Target to $120

Aadi Bioscience Reports Interim Results From PRECISION1 Trial Of Nab-Sirolimus Demonstrating Anti-Tumor Activity In Solid Tumors With TSC1 Or TSC2 Inactivating Alterations

Lithium Argentina Has Growth Potential, But Analyst Cautions About Valuation Concerns

Quotient Announces U.S. Launch Of Shopmium Cash-Back App To Enable Brands To Engage And Influence Consumers